Risk Factors for Renal Insufficiency and Survival Implications After Radical Nephrectomy and Thrombectomy in Renal Cell Carcinoma with Tumor Thrombus: a Systematic Review

Overview

Journal BMC Urol

Publisher Biomed Central

Date 2025 Jan 31

PMID 39891097

Authors

Zhigao Huang

Zhuo Liu

Lin Zhuo

Xin Ma

Zhenbin Jiang

Kewei Chen

Jiyuan Chen

Yuxuan Li

Guoliang Wang

Xiaojun Tian

Hongxian Zhang

Lei Liu

Lulin Ma

Kai Hong

Shudong Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Renal cell carcinoma (RCC) with venous tumor thrombus (VTT) is great burden over world. Radical nephrectomy (RN) with thrombectomy seems to be its gold standard operation, which might cause reduction of renal function. The aim of this systematic review was to provide evidence about the incidence, risk factors, possible reasons and influence of renal insufficiency in RCC patients undergoing RN with thrombectomy.

Methods: A systematic search using PubMed, Embase, Web of Science, the Cochrane Library and European Urology databases was conducted. Study selection followed the PRISMA guidelines. After screening, eleven articles and abstracted fully compatible with the PICOS were included in this systematic review. The study was registered with PROSPERO, CRD42024516596.

Results: Overall, a total of 1,668 patients who were diagnosed with RCC and VTT and underwent RN (open/laparoscopic/robotic) with thrombectomy were analyzed. The postoperative renal insufficiency was present from 0.7 to 53.9%. Relevant risk factors of postoperative renal insufficiency could be summarized into three aspects: baseline characteristics (male gender, tumor thrombus level), intraoperative procedure (surgical method and inferior vena cava clamping time) and other factors (development of the times). The reason of renal insufficiency could be depletion of circulation volume, alteration in renal hemodynamics and condition of solitary kidney. The overall survival (OS) ranged from 2 months to 98 months. A clear association between survival and renal function could not be established because of the oncological risk on survival. Necessary managements like supplying blood volume, diuretic therapy and renal replacement therapy should be applied.

Conclusions: The present incidence of postoperative renal insufficiency was underestimated. More possible risk factors should be explored. Large cohort, multi-center, prospective, and well-designed studies would be necessary to corroborate these results and provide high-grade recommendation for clinical practice.

References

Ma J, Sun W, Qian W, Min J, Zhang T, Yu D . Modified vein clamping technique for renal cell carcinoma complicated with level I-II IVC thrombi: a study at a single centre. BMC Urol. 2021; 21(1):179. PMC: 8691095. DOI: 10.1186/s12894-021-00947-9. View

Lo C, Mertz D, Loeb M . Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014; 14:45. PMC: 4021422. DOI: 10.1186/1471-2288-14-45. View

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009; 151(4):W65-94. DOI: 10.7326/0003-4819-151-4-200908180-00136. View

Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S . European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022; 82(4):399-410. DOI: 10.1016/j.eururo.2022.03.006. View

Khwaja A . KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120(4):c179-84. DOI: 10.1159/000339789. View

Kulkarni J, Acharya P, Rizvi S, Somaya A . Surgical management of renal cell carcinoma with inferior vena caval thrombus: a teaching hospital experience. Indian J Cancer. 2007; 44(2):45-50. DOI: 10.4103/0019-509x.35810. View

Roh G, Lee J, Nam S, Lee J, Choi J, Shim Y . Incidence and risk factors of acute kidney injury after thoracic aortic surgery for acute dissection. Ann Thorac Surg. 2012; 94(3):766-71. DOI: 10.1016/j.athoracsur.2012.04.057. View

Lardas M, Stewart F, Scrimgeour D, Hofmann F, Marconi L, Dabestani S . Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus. Eur Urol. 2015; 70(2):265-80. DOI: 10.1016/j.eururo.2015.11.034. View

Liu Z, Tang S, Tian X, Zhang H, Wang G, Zhang S . The effect of renal function change on renal cell carcinoma patients with tumor thrombus after nephrectomy and thrombectomy: a large Chinese center experience. BMC Cancer. 2020; 20(1):61. PMC: 6986031. DOI: 10.1186/s12885-020-6563-7. View

10.

Blute M, Leibovich B, Lohse C, Cheville J, Zincke H . The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004; 94(1):33-41. DOI: 10.1111/j.1464-410X.2004.04897.x. View

11.

Chung B, Leow J, Gelpi-Hammerschmidt F, Wang Y, Del Giudice F, De S . Racial Disparities in Postoperative Complications After Radical Nephrectomy: A Population-based Analysis. Urology. 2015; 85(6):1411-6. DOI: 10.1016/j.urology.2015.03.001. View

12.

Zabor E, Furberg H, Lee B, Campbell S, Lane B, Thompson R . Long-Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study. J Urol. 2017; 199(4):921-926. PMC: 6226274. DOI: 10.1016/j.juro.2017.10.027. View

13.

Gayed B, Youssef R, Darwish O, Kapur P, Bagrodia A, Brugarolas J . Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned. BMC Urol. 2016; 16(1):43. PMC: 4952069. DOI: 10.1186/s12894-016-0157-3. View

14.

Thangarasu M, Prakash J, Bafna S, Aarthy P, Govindaswamy T, Venugopal B . Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma: A 7-year single-center experience. Urol Ann. 2022; 14(3):273-278. PMC: 9472312. DOI: 10.4103/UA.UA_169_20. View

15.

Shin S, Han Y, Park H, Chung Y, Ahn H, Kim C . Risk factors for acute kidney injury after radical nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma. J Vasc Surg. 2013; 58(4):1021-7. DOI: 10.1016/j.jvs.2013.02.247. View

16.

Yuan S . Surgical treatment of renal cell carcinoma with inferior vena cava tumor thrombus. Surg Today. 2022; 52(8):1125-1133. DOI: 10.1007/s00595-021-02429-9. View

17.

Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M . Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018; 103:356-387. DOI: 10.1016/j.ejca.2018.07.005. View

18.

Ishiyama Y, Kondo T, Tachibana H, Ishihara H, Yoshida K, Takagi T . Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus. Urol Oncol. 2022; 40(3):110.e11-110.e18. DOI: 10.1016/j.urolonc.2021.12.013. View

19.

Zhang Y, Bi H, Yan Y, Liu Z, Wang G, Song Y . Comparative analysis of surgical and oncologic outcomes of robotic, laparoscopic and open radical nephrectomy with venous thrombectomy: a propensity-matched cohort study. Int J Clin Oncol. 2022; 28(1):145-154. DOI: 10.1007/s10147-022-02265-y. View

20.

Klarenbach S, Moore R, Chapman D, Dong J, Braam B . Adverse renal outcomes in subjects undergoing nephrectomy for renal tumors: a population-based analysis. Eur Urol. 2010; 59(3):333-9. DOI: 10.1016/j.eururo.2010.11.013. View